JP2002128654A - Skin care preparation - Google Patents
Skin care preparationInfo
- Publication number
- JP2002128654A JP2002128654A JP2000327317A JP2000327317A JP2002128654A JP 2002128654 A JP2002128654 A JP 2002128654A JP 2000327317 A JP2000327317 A JP 2000327317A JP 2000327317 A JP2000327317 A JP 2000327317A JP 2002128654 A JP2002128654 A JP 2002128654A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- acid
- derivatives
- cream
- silane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 31
- 239000000284 extract Substances 0.000 claims abstract description 53
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 claims abstract description 22
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 claims abstract description 22
- 229960004705 kojic acid Drugs 0.000 claims abstract description 22
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 claims abstract description 20
- 241000233855 Orchidaceae Species 0.000 claims abstract description 15
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 12
- 235000009566 rice Nutrition 0.000 claims abstract description 12
- 241000196324 Embryophyta Species 0.000 claims abstract description 10
- 229960000271 arbutin Drugs 0.000 claims abstract description 10
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 claims abstract description 10
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 claims abstract description 8
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 claims abstract description 8
- 229920002079 Ellagic acid Polymers 0.000 claims abstract description 8
- 229960002852 ellagic acid Drugs 0.000 claims abstract description 8
- 235000004132 ellagic acid Nutrition 0.000 claims abstract description 8
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 claims abstract description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 7
- 239000007844 bleaching agent Substances 0.000 claims abstract description 7
- 229960005070 ascorbic acid Drugs 0.000 claims abstract description 5
- 150000005207 1,3-dihydroxybenzenes Chemical class 0.000 claims abstract description 4
- 210000002826 placenta Anatomy 0.000 claims abstract description 4
- 235000010323 ascorbic acid Nutrition 0.000 claims abstract description 3
- 239000011668 ascorbic acid Substances 0.000 claims abstract description 3
- 240000007594 Oryza sativa Species 0.000 claims abstract 3
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 claims description 31
- 229910000077 silane Inorganic materials 0.000 claims description 31
- 230000002087 whitening effect Effects 0.000 claims description 28
- 239000003795 chemical substances by application Substances 0.000 claims description 16
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 claims description 8
- CSHZYWUPJWVTMQ-UHFFFAOYSA-N 4-n-Butylresorcinol Chemical compound CCCCC1=CC=C(O)C=C1O CSHZYWUPJWVTMQ-UHFFFAOYSA-N 0.000 claims description 4
- 235000020712 soy bean extract Nutrition 0.000 claims description 2
- 244000068988 Glycine max Species 0.000 claims 1
- 235000010469 Glycine max Nutrition 0.000 claims 1
- 230000007062 hydrolysis Effects 0.000 claims 1
- 238000006460 hydrolysis reaction Methods 0.000 claims 1
- 229910052749 magnesium Inorganic materials 0.000 claims 1
- 239000011777 magnesium Substances 0.000 claims 1
- 208000012641 Pigmentation disease Diseases 0.000 abstract description 22
- 230000019612 pigmentation Effects 0.000 abstract description 21
- 206010014970 Ephelides Diseases 0.000 abstract description 4
- 208000003351 Melanosis Diseases 0.000 abstract description 4
- 208000024891 symptom Diseases 0.000 abstract description 4
- 241001313855 Bletilla Species 0.000 abstract 1
- 240000000249 Morus alba Species 0.000 abstract 1
- 235000008708 Morus alba Nutrition 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 239000006071 cream Substances 0.000 description 33
- -1 kojic acid ethers Chemical class 0.000 description 33
- 239000000243 solution Substances 0.000 description 32
- 238000004519 manufacturing process Methods 0.000 description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- 239000000419 plant extract Substances 0.000 description 15
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 11
- 235000014113 dietary fatty acids Nutrition 0.000 description 11
- 239000000194 fatty acid Substances 0.000 description 11
- 229930195729 fatty acid Natural products 0.000 description 11
- 206010015150 Erythema Diseases 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 10
- 231100000321 erythema Toxicity 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 241000209094 Oryza Species 0.000 description 9
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 239000000843 powder Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 238000013329 compounding Methods 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 229940057995 liquid paraffin Drugs 0.000 description 4
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 4
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 4
- 229960002216 methylparaben Drugs 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 230000002195 synergetic effect Effects 0.000 description 4
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 4
- 229940058015 1,3-butylene glycol Drugs 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241001167064 Bletilla formosana Species 0.000 description 3
- 241001313857 Bletilla striata Species 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- ACFGRWJEQJVZTM-LEJBHHMKSA-L Magnesium L-ascorbic acid-2-phosphate Chemical compound [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])([O-])=O)=C1O ACFGRWJEQJVZTM-LEJBHHMKSA-L 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229920001214 Polysorbate 60 Polymers 0.000 description 3
- 206010040880 Skin irritation Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 241000700199 Cavia porcellus Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 239000002211 L-ascorbic acid Substances 0.000 description 2
- 150000000996 L-ascorbic acids Chemical class 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 125000005037 alkyl phenyl group Chemical group 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000012736 aqueous medium Substances 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 159000000003 magnesium salts Chemical class 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- 150000005208 1,4-dihydroxybenzenes Chemical class 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- JKRDADVRIYVCCY-UHFFFAOYSA-N 2-hydroxyoctanoic acid Chemical compound CCCCCCC(O)C(O)=O JKRDADVRIYVCCY-UHFFFAOYSA-N 0.000 description 1
- HWLBIEAKJSRKOD-UHFFFAOYSA-N 2-octadecanoyloxyacetic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)=O HWLBIEAKJSRKOD-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- NYARJMRXCRSQPJ-UHFFFAOYSA-N 4-(3-methylbutyl)benzene-1,3-diol Chemical compound CC(C)CCC1=CC=C(O)C=C1O NYARJMRXCRSQPJ-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 102100022749 Aminopeptidase N Human genes 0.000 description 1
- 101710099461 Aminopeptidase N Proteins 0.000 description 1
- 241001656044 Bletilla ochracea Species 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- MDNWOSOZYLHTCG-UHFFFAOYSA-N Dichlorophen Chemical compound OC1=CC=C(Cl)C=C1CC1=CC(Cl)=CC=C1O MDNWOSOZYLHTCG-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- ILKBHIBYKSHTKQ-UHFFFAOYSA-N Diisopropylamine dichloroacetate Chemical compound OC(=O)C(Cl)Cl.CC(C)NC(C)C ILKBHIBYKSHTKQ-UHFFFAOYSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- MIJPAVRNWPDMOR-ZAFYKAAXSA-N L-ascorbic acid 2-phosphate Chemical group OC[C@H](O)[C@H]1OC(=O)C(OP(O)(O)=O)=C1O MIJPAVRNWPDMOR-ZAFYKAAXSA-N 0.000 description 1
- XDBMXUKHMOFBPJ-ZAFYKAAXSA-N L-ascorbic acid 2-sulfate Chemical class OC[C@H](O)[C@H]1OC(=O)C(OS(O)(=O)=O)=C1O XDBMXUKHMOFBPJ-ZAFYKAAXSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241001072282 Limnanthes Species 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- RJUFJBKOKNCXHH-UHFFFAOYSA-N Methyl propionate Chemical compound CCC(=O)OC RJUFJBKOKNCXHH-UHFFFAOYSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- OFUHPGMOWVHNPN-QWZFGMNQSA-N [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] (9z,12z)-octadeca-9,12-dienoate Chemical compound O1[C@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CCC2=C(C)C(OC(=O)CCCCCCC\C=C/C\C=C/CCCCC)=C(C)C(C)=C21 OFUHPGMOWVHNPN-QWZFGMNQSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000004996 alkyl benzenes Chemical class 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960002298 aminohydroxybutyric acid Drugs 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 229940062909 amyl salicylate Drugs 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229920003090 carboxymethyl hydroxyethyl cellulose Polymers 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 1
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229960003887 dichlorophen Drugs 0.000 description 1
- 229940084113 diisopropylamine dichloroacetate Drugs 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- HPMLGOFBKNGJAM-ONEGZZNKSA-N ethyl (e)-3-(1h-imidazol-5-yl)prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CN=CN1 HPMLGOFBKNGJAM-ONEGZZNKSA-N 0.000 description 1
- NYNCZOLNVTXTTP-UHFFFAOYSA-N ethyl 2-(1,3-dioxoisoindol-2-yl)acetate Chemical compound C1=CC=C2C(=O)N(CC(=O)OCC)C(=O)C2=C1 NYNCZOLNVTXTTP-UHFFFAOYSA-N 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- YQGDEPYYFWUPGO-UHFFFAOYSA-N gamma-amino-beta-hydroxybutyric acid Chemical compound [NH3+]CC(O)CC([O-])=O YQGDEPYYFWUPGO-UHFFFAOYSA-N 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 1
- 229940117841 methacrylic acid copolymer Drugs 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229940017219 methyl propionate Drugs 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- WIBFFTLQMKKBLZ-SEYXRHQNSA-N n-butyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCCC WIBFFTLQMKKBLZ-SEYXRHQNSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- VIKVSUVYUVJHOA-UHFFFAOYSA-N octyl 3-phenylprop-2-enoate Chemical compound CCCCCCCCOC(=O)C=CC1=CC=CC=C1 VIKVSUVYUVJHOA-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical group 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、すぐれた美白効果
を有し、シミ、ソバカス等の皮膚の色素沈着の予防並び
に症状改善に有効な皮膚外用剤に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an external preparation for skin which has an excellent whitening effect and is effective for preventing skin pigmentation such as spots and freckles and improving symptoms.
【0002】[0002]
【従来の技術】日焼け或いは加齢に伴って生ずる色素沈
着、特にシミ、ソバカスの予防、症状改善を目的とし
て、従来よりコウジ酸、アスコルビン酸誘導体、ハイド
ロキノン誘導体など種々の美白剤が提案され、これらを
配合した皮膚外用剤が上市されている。しかしながら、
それら従来の美白剤は、美白効果それ自体が必ずしも満
足できるものではないことに加えて、美白効果を最大限
に発揮させるため配合量を増やすと、皮膚刺激の問題を
生ずることがあるなど、実用性の面でなお改善すべき点
が多い。2. Description of the Related Art Various whitening agents such as kojic acid, ascorbic acid derivatives and hydroquinone derivatives have been proposed for the purpose of preventing pigmentation caused by sunburn or aging, particularly spots and freckles, and improving symptoms. An external preparation for skin containing is marketed. However,
In addition to the fact that the whitening effect itself is not always satisfactory, those conventional whitening agents may cause problems such as skin irritation when the amount is increased to maximize the whitening effect. There are still many points to be improved in terms of sex.
【0003】本発明者等は、かかる従来技術の問題点に
鑑み、美白効果にすぐれ、かつ安全性の高い皮膚外用剤
を提供すべく鋭意研究を進めた結果、コウジ酸、アルブ
チン等の既存の美白剤とラン科シラン属植物の抽出物と
を組み合わせ用いた場合、それらの相乗的作用により美
白効果が著しく向上し、これにより美白・美肌化効果の
一段と改善された皮膚外用剤の提供が可能となること、
又美白効果の向上の結果として、低配合量でもすぐれた
美白効果が期待できることから、皮膚刺激の心配の少な
い安全性にすぐれた皮膚外用剤を提供し得ることを見出
し本発明を完成した。[0003] In view of the problems of the prior art, the present inventors have conducted intensive studies to provide a skin external preparation having an excellent whitening effect and high safety. When a combination of a whitening agent and an extract of a plant belonging to the genus Silane belongs to the synergistic action, the whitening effect is remarkably improved, thereby providing a skin external preparation with a further improved whitening / skinning effect. To be
Further, as a result of the improvement of the whitening effect, an excellent whitening effect can be expected even at a low blending amount. Therefore, the present inventors have found that it is possible to provide a highly safe skin external preparation with little fear of skin irritation, and completed the present invention.
【0004】即ち本発明は、ラン科シラン属に属する植
物の抽出物とコウジ酸及びその誘導体、アルブチン、ア
スコルビン酸及びその誘導体、エラグ酸、レゾルシノー
ル誘導体、胎盤抽出物、ソウハクヒ抽出液及び米糠抽出
物加水分解物から選ばれた美白剤の1種又は2種以上とを
配合してなる皮膚外用剤である。That is, the present invention relates to an extract of a plant belonging to the genus Silane of the orchid family and kojic acid and its derivatives, arbutin, ascorbic acid and its derivatives, ellagic acid, resorcinol derivatives, placenta extract, soybean extract and rice bran extract It is an external preparation for skin prepared by blending one or more whitening agents selected from hydrolysates.
【0005】以下、本発明について詳細に説明する。本
発明で用いるラン科シラン属植物の抽出物は、シラン(B
letilla striata)、ブレティラ・ホルモサーナ(B. form
osana)、ブレティラ・オキラシア(B. ochracea)、ブレ
ティラ・ツエチュアニカ(B. szetschuanica)などのシラ
ン属植物の全草、葉、球茎、根等を、必要に応じて乾
燥、細切等の前処理を施した上、適宜の溶媒で抽出して
得られるものである。本発明に於いては、それらシラン
属植物のうちでも特にシラン(Bletilla striata)の使用
が好ましく、又抽出対象部位としては球茎が最も好まし
い。Hereinafter, the present invention will be described in detail. The extract of the orchid silane plant used in the present invention is a silane (B
letilla striata), Bretira Hormosana (B. form
osana), Bretilla okiracea (B. ochracea), Bretilla tsuzechuanica (B. szetschuanica), etc., whole plants, leaves, corms, roots, etc. And obtained by extraction with an appropriate solvent. In the present invention, among these silane plants, the use of silane (Bletilla striata) is particularly preferred, and a corm is most preferred as a site to be extracted.
【0006】抽出に用いる溶媒としては、水;メタノー
ル、エタノールなどの低級アルコール類;エチレングリ
コール、プロピレングリコール、1,3−ブチレングリ
コール、1,2−ペンタンジオール、グリセリンなどの
多価アルコール類;酢酸エチル、酢酸ブチル、プロピオ
ン酸メチルなどのエステル類;アセトン、メチルエチル
ケトンなどのケトン類;エチルエーテル、イソプロピル
エーテルなどのエーテル類;ヘキサン、トルエン、クロ
ロホルムなどの炭化水素系溶媒等があり、それらはpH
調整なしで、もしくは酸、アルカリなどでpH調整を行
った上使用される。それらのうちでも、本発明に於いて
は水性媒体、例えば水、水と低級アルコール類との混液
もしくは水と多価アルコール類との混液等の使用が最も
好ましい。Examples of the solvent used for the extraction include water; lower alcohols such as methanol and ethanol; polyhydric alcohols such as ethylene glycol, propylene glycol, 1,3-butylene glycol, 1,2-pentanediol and glycerin; Esters such as ethyl, butyl acetate and methyl propionate; ketones such as acetone and methyl ethyl ketone; ethers such as ethyl ether and isopropyl ether; hydrocarbon solvents such as hexane, toluene and chloroform;
It is used without any adjustment or after adjusting the pH with an acid or alkali. Among them, in the present invention, it is most preferable to use an aqueous medium such as water, a mixed solution of water and lower alcohols or a mixed solution of water and polyhydric alcohols.
【0007】抽出条件は、用いる溶媒の種類、被抽出物
の性状等によっても異なるが、一般には、4〜80℃で2
時間〜3日間程度であり、上記の水性媒体を用いる場合
であれば、20〜60℃で4〜24時間抽出を行うのが好適で
ある。[0007] The extraction conditions vary depending on the type of solvent used, the properties of the extract, and the like.
When the above aqueous medium is used, it is preferable to perform extraction at 20 to 60 ° C. for 4 to 24 hours.
【0008】ここに得られるラン科シラン属植物抽出物
溶液は、一般にはpH4〜8に調整した上、そのままも
しくはさらに適宜の濃度に調整して使用するか、場合に
よっては、スプレードライ法、凍結乾燥法など常法に従
って粉末化して使用される。The orchid family silane plant extract solution obtained here is generally adjusted to pH 4 to 8, and used as it is or after adjusting to an appropriate concentration. Powdered and used according to a conventional method such as a drying method.
【0009】本発明に於いて、上記のラン科シラン属植
物抽出物と組み合わせ用いる美白剤中、コウジ酸誘導体
としては、例えばコウジ酸モノブチレート、コウジ酸モ
ノカプレート、コウジ酸モノパルミテート、コウジ酸ジ
ブチレートなどのコウジ酸エステル類、或いはコウジ酸
エーテル類;アスコルビン酸誘導体としては、例えばL
−アスコルビン酸−2−リン酸エステル塩、L−アスコ
ルビン酸−2−硫酸エステル塩などのアスコルビン酸エ
ステル塩類(塩はナトリウム塩、マグネシウム塩な
ど)、L−アスコルビン酸−2−グルコシド(2−O−
α−D−グルコピラノシル−L−アスコルビン酸)、L
−アスコルビン酸−5−グルコシド(5−O−α−D−
グルコピラノシル−L−アスコルビン酸)などのアスコ
ルビン酸糖誘導体;レゾルシノール誘導体としては、例
えば4−n−ブチルレゾルシノール、4−イソアミルレ
ゾルシノール等がある。又、胎盤抽出物としては、化粧
品公定書に収載されている化粧品配合グレードのもの
が、米糠抽出物加水分解物としては、特開平5-221844号
公報に記載の方法、特に酵素処理を用いる方法によって
得られる加水分解物が好適に使用できる。In the present invention, the kojic acid derivative in the whitening agent used in combination with the above-mentioned silane plant extract of the family Orchidaceae includes, for example, kojic acid monobutyrate, kojic acid monocaprate, kojic acid monopalmitate, kojic acid dibutyrate. Esters or kojic acid ethers such as citrate; ascorbic acid derivatives include, for example, L
-Ascorbic acid ester salts such as ascorbic acid-2-phosphate ester salt, L-ascorbic acid-2-sulfate salt (the salt is sodium salt, magnesium salt and the like), L-ascorbic acid-2-glucoside (2-O −
α-D-glucopyranosyl-L-ascorbic acid), L
-Ascorbic acid-5-glucoside (5-O-α-D-
Ascorbic acid sugar derivatives such as glucopyranosyl-L-ascorbic acid); examples of resorcinol derivatives include 4-n-butyl resorcinol and 4-isoamyl resorcinol. Further, as the placenta extract, those of cosmetic compounding grades listed in the official cosmetics of cosmetics, and as the rice bran extract hydrolyzate, the method described in JP-A-5-221844, particularly a method using enzyme treatment The hydrolyzate obtained by the above can be suitably used.
【0010】本発明に於いて、ラン科シラン属植物抽出
物と組み合わせ用いる美白剤のうちでも、特にコウジ
酸、アルブチン、L−アスコルビン酸−2−リン酸エス
テルマグネシウム塩、L−アスコルビン酸−2−グルコ
シドが、得られる美白効果の点から好ましい。In the present invention, among the whitening agents used in combination with the plant extract of the genus Silane in the family Orchidaceae, in particular, kojic acid, arbutin, L-ascorbic acid-2-phosphate magnesium salt, L-ascorbic acid-2. -Glucoside is preferred in view of the whitening effect obtained.
【0011】ラン科シラン属植物抽出物とそれら美白剤
との配合比は、固形分重量比で10:1〜1:100の範囲
であり、好ましくは5:1〜1:50、特に好ましくは
2:1〜1:40の範囲である。ラン科シラン属植物抽出
物に対する美白剤の配合比が、1:100を上回るかもし
くは10:1を下回ると、相乗効果が発揮され難くなり、
組み合わせのメリットが低下する。The compounding ratio of the orchid silane plant extract and the whitening agent is in the range of 10: 1 to 1: 100, preferably 5: 1 to 1:50, more preferably 5: 1 to 1: 100 in terms of solids weight ratio. The range is from 2: 1 to 1:40. When the compounding ratio of the whitening agent to the orchid silane plant extract is more than 1: 100 or less than 10: 1, the synergistic effect is hardly exhibited,
The merit of the combination decreases.
【0012】本発明の皮膚外用剤中に於けるラン科シラ
ン属植物抽出物と美白剤の配合量は、上記の配合比の範
囲で、ラン科シラン属植物抽出物の場合、固形分として
一般に0.002〜1.0重量%、好ましくは0.02〜0.5重量
%、又美白剤の場合一般に0.1〜10重量%、好ましくは
0.5〜5重量%の範囲である。配合量が上記の範囲を下
回ると、十分な美白・美肌化効果は得難く、一方上記の
範囲以上としても、美白効果の一層の向上は期待し難い
だけでなく、コスト面で不利となる問題等があっていず
れも好ましくない。The amount of the orchid silane plant extract and the whitening agent in the skin external preparation of the present invention is generally within the range of the above-mentioned compounding ratio. 0.002 to 1.0% by weight, preferably 0.02 to 0.5% by weight, and in the case of whitening agents generally 0.1 to 10% by weight, preferably
It is in the range of 0.5-5% by weight. If the amount is less than the above range, it is difficult to obtain a sufficient whitening / skinning effect. On the other hand, if the amount is more than the above range, further improvement of the whitening effect is not expected, and disadvantageous in cost. All are not preferred.
【0013】本発明の皮膚外用剤は、化粧料、医薬部外
品、医薬等のいずれとしても使用可能であり、又その剤
形としては、例えばクリーム、乳液、ローション、軟
膏、パック、ハップ剤など用途、適用対象等に応じて多
様なものが採用できる。The external preparation for skin of the present invention can be used as any of cosmetics, quasi-drugs, medicaments and the like, and its dosage form is, for example, cream, emulsion, lotion, ointment, pack, haptic Various things can be adopted according to the use, the application object, etc.
【0014】本発明の皮膚外用剤には、必須成分のラン
科シラン属植物抽出物及び美白剤のほかに、通常皮膚外
用剤に用いられる成分、例えば油性成分、界面活性剤、
保湿剤、増粘剤、防腐・殺菌剤、粉体成分、紫外線吸収
剤、抗酸化剤、色素、香料等を必要に応じて適宜配合す
ることができる。The external preparation for skin of the present invention includes, in addition to the essential components, an extract of a plant belonging to the genus Orchidaceae and a whitening agent, components commonly used in external preparations for skin, such as oily components and surfactants.
A humectant, a thickener, a preservative / disinfectant, a powder component, an ultraviolet absorber, an antioxidant, a dye, a fragrance, and the like can be appropriately compounded as needed.
【0015】ここで、油性成分としては、例えばオリー
ブ油、ホホバ油、ヒマシ油、大豆油、ヤシ油、パーム
油、カカオ油、メドウフォーム油などの植物由来の油脂
類;ミンク油、タートル油などの動物由来の油脂類;ミ
ツロウ、カルナウバロウ、ラノリンなどのロウ類;流動
パラフィン、ワセリン、パラフィンワックス、スクワラ
ンなどの炭化水素類;ミリスチン酸、パルミチン酸、ス
テアリン酸、オレイン酸、イソステアリン酸などの脂肪
酸類;ラウリルアルコール、セタノール、ステアリルア
ルコールなどの高級アルコール類;ミリスチン酸イソプ
ロピル、オレイン酸ブチル、2−エチルヘキシルグリセ
ライドなどの合成エステル類及び合成トリグリセライド
類等が挙げられる。[0015] Here, as the oily component, for example, plant-derived fats and oils such as olive oil, jojoba oil, castor oil, soybean oil, coconut oil, palm oil, cacao oil and meadowfoam oil; mink oil and turtle oil Animal-derived fats and oils; waxes such as beeswax, carnauba wax and lanolin; hydrocarbons such as liquid paraffin, vaseline, paraffin wax and squalane; fatty acids such as myristic acid, palmitic acid, stearic acid, oleic acid, isostearic acid; Higher alcohols such as lauryl alcohol, cetanol and stearyl alcohol; synthetic esters such as isopropyl myristate, butyl oleate, and 2-ethylhexyl glyceride; and synthetic triglycerides.
【0016】界面活性剤としては、例えばポリオキシエ
チレンアルキルエーテル、ポリオキシエチレン脂肪酸エ
ステル、ポリオキシエチレンソルビタン脂肪酸エステ
ル、グリセリン脂肪酸エステル、ポリグリセリン脂肪酸
エステル、ポリオキシエチレングリセリン脂肪酸エステ
ル、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチ
レンソルビトール脂肪酸エステルなどの非イオン界面活
性剤;脂肪酸塩、アルキル硫酸塩、アルキルベンゼンス
ルホン酸塩、ポリオキシエチレンアルキルエーテル硫酸
塩、ポリオキシエチレン脂肪アミン硫酸塩、ポリオキシ
エチレンアルキルフェニルエーテル硫酸塩、ポリオキシ
エチレンアルキルエーテル燐酸塩、α−スルホン化脂肪
酸アルキルエステル塩、ポリオキシエチレンアルキルフ
ェニルエーテル燐酸塩などのアニオン界面活性剤;第四
級アンモニウム塩、第一級〜第三級脂肪アミン塩、トリ
アルキルベンジルアンモニウム塩、アルキルピリジニウ
ム塩、2−アルキル−1−アルキル−1−ヒドロキシエ
チルイミダゾリニウム塩、N、N−ジアルキルモルフォ
ルニウム塩、ポリエチレンポリアミン脂肪酸アミド塩な
どのカチオン界面活性剤;N、N−ジメチル−N−アル
キル−N−カルボキシメチルアンモニオベタイン、N、
N、N−トリアルキル−N−アルキレンアンモニオカル
ボキシベタイン、N−アシルアミドプロピル−N′、
N′−ジメチル−N′−β−ヒドロキシプロピルアンモ
ニオスルホベタインなどの両性界面活性剤等が挙げられ
る。Examples of the surfactant include polyoxyethylene alkyl ether, polyoxyethylene fatty acid ester, polyoxyethylene sorbitan fatty acid ester, glycerin fatty acid ester, polyglycerin fatty acid ester, polyoxyethylene glycerin fatty acid ester, and polyoxyethylene cured castor. Non-ionic surfactants such as oils and polyoxyethylene sorbitol fatty acid esters; fatty acid salts, alkyl sulfates, alkyl benzene sulfonates, polyoxyethylene alkyl ether sulfates, polyoxyethylene fatty amine sulfates, polyoxyethylene alkyl phenyl ethers Sulfate, polyoxyethylene alkyl ether phosphate, α-sulfonated fatty acid alkyl ester salt, polyoxyethylene alkyl phenyl ether phosphate Quaternary ammonium salts, primary to tertiary fatty amine salts, trialkylbenzylammonium salts, alkylpyridinium salts, 2-alkyl-1-alkyl-1-hydroxyethylimidazolinium salts , N, N-dialkylmorphonium salts, cationic surfactants such as polyethylene polyamine fatty acid amide salts; N, N-dimethyl-N-alkyl-N-carboxymethylammonio betaine;
N, N-trialkyl-N-alkyleneammoniocarboxybetaine, N-acylamidopropyl-N ',
And amphoteric surfactants such as N'-dimethyl-N'-β-hydroxypropylammoniosulfobetaine.
【0017】保湿剤としては、例えばグリセリン、プロ
ピレングリコール、ジプロピレングリコール、1、3−
ブチレングリコール、ポリエチレングリコール、ソルビ
トール、キシリトール、ピロリドンカルボンナトリウム
等があり、さらに糖類、ヒアルロン酸、乳酸、尿素、高
級脂肪酸オクチルドデシル、各種アミノ酸及びそれらの
誘導体が挙げられる。Examples of humectants include glycerin, propylene glycol, dipropylene glycol, 1,3-
Examples include butylene glycol, polyethylene glycol, sorbitol, xylitol, sodium pyrrolidone carboxylate, and further include saccharides, hyaluronic acid, lactic acid, urea, higher fatty acid octyldodecyl, various amino acids, and derivatives thereof.
【0018】増粘剤としては、例えばカラギーナン、ア
ルギン酸、ペクチン、ローカストビーンガムなどの多糖
類;キサンタンガム、トラガカントガム、グアーガムな
どのガム類;カルボキシメチルセルロース、ヒドロキシ
エチルセルロースなどのセルロース誘導体;ポリビニル
アルコール、ポリビニルピロリドン、カルボキシビニル
ポリマー、アクリル酸・メタクリル酸共重合体などの合
成高分子類;ヒアルロン酸及びその誘導体等が挙げられ
る。Examples of the thickener include polysaccharides such as carrageenan, alginic acid, pectin and locust bean gum; gums such as xanthan gum, tragacanth gum and guar gum; cellulose derivatives such as carboxymethyl cellulose and hydroxyethyl cellulose; polyvinyl alcohol, polyvinyl pyrrolidone; Synthetic polymers such as carboxyvinyl polymer and acrylic acid / methacrylic acid copolymer; hyaluronic acid and its derivatives;
【0019】防腐殺菌剤としては、例えば尿素;パラオ
キシ安息香酸メチル、パラオキシ安息香酸エチル、パラ
オキシ安息香酸プロピル、パラオキシ安息香酸ブチルな
どのパラオキシ安息香酸エステル類;フェノキシエタノ
ール、ジクロロフェン、ヘキサクロロフェン、塩酸クロ
ルヘキシジン、塩化ベンザルコニウム、サリチル酸、エ
タノール、ウンデシレン酸、フェノール類、ジャマール
(イミダゾデイニールウレア)等がある。Examples of the preservative disinfectant include urea; paraoxybenzoic acid esters such as methyl paraoxybenzoate, ethyl paraoxybenzoate, propyl paraoxybenzoate and butyl paraoxybenzoate; phenoxyethanol, dichlorophen, hexachlorophen, chlorhexidine hydrochloride, Examples include benzalkonium chloride, salicylic acid, ethanol, undecylenic acid, phenols, and jamal (imidazodeinyl urea).
【0020】粉体成分としては、例えばセリサイト、酸
化チタン、タルク、カオリン、ベントナイト、酸化亜
鉛、炭酸マグネシウム、酸化マグネシウム、酸化ジルコ
ニウム、硫酸バリウム、無水ケイ酸、雲母、ナイロンパ
ウダー等がある。Examples of the powder component include sericite, titanium oxide, talc, kaolin, bentonite, zinc oxide, magnesium carbonate, magnesium oxide, zirconium oxide, barium sulfate, silicic anhydride, mica, and nylon powder.
【0021】紫外線吸収剤としては、例えばパラアミノ
安息香酸エチル、パラジメチルアミノ安息香酸エチルヘ
キシル、サリチル酸アミル及びその誘導体、パラメトキ
シ桂皮酸エチルヘキシル、桂皮酸オクチル、2、4−ジ
ヒドロキシベンゾフェノン、2−ヒドロキシ−4−メト
キシベンゾフェノン−5−スルホン酸塩、2−(2−ヒ
ドロキシ−5−メチルフェニル)ベンゾトリアゾール、
ウロカニン酸、ウロカニン酸エチル等がある。Examples of the ultraviolet absorber include ethyl paraaminobenzoate, ethylhexyl paradimethylaminobenzoate, amyl salicylate and derivatives thereof, ethylhexyl paramethoxycinnamate, octyl cinnamate, 2,4-dihydroxybenzophenone, 2-hydroxy-4- Methoxybenzophenone-5-sulfonate, 2- (2-hydroxy-5-methylphenyl) benzotriazole,
There are urocanic acid, ethyl urocanate and the like.
【0022】抗酸化剤としては、例えばブチルヒドロキ
シアニソール、ブチルヒドロキシトルエン、没食子酸プ
ロピル、ビタミンE及びその誘導体等がある。又、その
他の成分として、レシチン類、シルク関連物質等を配合
することもできる。Examples of the antioxidant include butylhydroxyanisole, butylhydroxytoluene, propyl gallate, vitamin E and derivatives thereof. Further, as other components, lecithins, silk-related substances and the like can be blended.
【0023】本発明の皮膚外用剤には、本発明の組み合
わせ成分の有効性を損なわない範囲で、さらに他の生理
活性成分を配合してもよい。かかるものとしては、例え
ばコラーゲン、ニコチン酸及びその誘導体(例えばニコ
チン酸アミド、ニコチン酸ベンジル等)、ビタミンE及び
その誘導体(例えばビタミンEニコチネート、ビタミン
Eリノレート等)、α−ヒドロキシ酸類(例えば乳酸、
クエン酸、α−ヒドロキシオクタン酸等)、ジイソプロ
ピルアミンジクロロアセテート、γ−アミノ−β−ヒド
ロキシ酪酸などの皮膚老化防止・肌荒れ改善成分;ゲン
チアナエキスなどの生薬抽出エキス等がある。The external preparation for skin of the present invention may further contain other physiologically active ingredients as long as the effectiveness of the combination component of the present invention is not impaired. Such substances include, for example, collagen, nicotinic acid and its derivatives (eg, nicotinamide, benzyl nicotinate, etc.), vitamin E and its derivatives (eg, vitamin E nicotinate, vitamin E linoleate, etc.), α-hydroxy acids (eg, lactic acid,
Citric acid, α-hydroxyoctanoic acid, etc.), diisopropylamine dichloroacetate, γ-amino-β-hydroxybutyric acid, etc., components for preventing skin aging and improving skin roughness; extracts of crude drugs such as gentian extract.
【0024】次に、製造例、実施例(処方例)及び試験例
によって本発明をさらに具体的に説明するが、本発明は
それらに限定されるものではない。なお、以下に於い
て、部はすべて重量部を、また%はすべて重量%を意味
する。Next, the present invention will be described more specifically with reference to Production Examples, Examples (formulation examples) and Test Examples, but the invention is not limited thereto. In the following, all parts are parts by weight, and all parts are by weight.
【0025】 製造例1.シラン属植物抽出物溶液の調製(1) シラン属シラン(Bletilla striata)の球茎の乾燥細切物
100gに精製水900gを加え、50℃で15時間抽出した。得
られた抽出液をろ過して、淡黄色透明の抽出物溶液(固
形分含量:約3.3%)300mlを得た。Production Example 1 Preparation of silane plant extract solution (1) Dried slices of corm of silane (Bletilla striata)
900 g of purified water was added to 100 g and extracted at 50 ° C. for 15 hours. The obtained extract was filtered to obtain 300 ml of a pale yellow transparent extract solution (solid content: about 3.3%).
【0026】 製造例2.シラン属植物抽出物溶液の調製(2) シラン属シランの球茎の乾燥細切物100gに精製水900g
を加え、60℃で4時間抽出した。得られた抽出液をろ過
して、淡黄色透明の抽出物溶液(固形分含量:約2.6
%)350mlを得た。Production Example 2 Preparation of Silane Plant Extract Solution (2) 900 g of purified water per 100 g of dry sliced corm of silane silane
And extracted at 60 ° C. for 4 hours. The obtained extract was filtered to give a pale yellow transparent extract solution (solid content: about 2.6
%) 350 ml were obtained.
【0027】 製造例3.シラン属植物抽出物溶液の調製(3) シラン属シランの球茎の乾燥細切物100gに50%エタノ
ール水溶液900gを加え、室温(25℃)で15時間抽出し
た。得られた抽出液をろ過して、淡黄色透明の抽出物溶
液(固形分含量:約0.9%)600mlを得た。Production Example 3 Preparation of Silane Plant Extract Solution (3) 900 g of a 50% aqueous ethanol solution was added to 100 g of dried and finely cut corms of silane silane, and extracted at room temperature (25 ° C.) for 15 hours. The obtained extract was filtered to obtain 600 ml of a pale yellow transparent extract solution (solid content: about 0.9%).
【0028】 製造例4.シラン属植物抽出物溶液の調製(4) シラン属シラン(Bletilla striata)の球茎の乾燥細切物
100gに5%1,2−ペンタンジオール水溶液900gを加
え、室温(25℃)で15時間抽出した。得られた抽出液を
ろ過して、淡黄色透明の抽出物溶液(固形分含量:約1.
2%)500mlを得た。Production Example 4 Preparation of silane plant extract solution (4) Dried slices of corm of silane (Bletilla striata)
900 g of a 5% 1,2-pentanediol aqueous solution was added to 100 g, and the mixture was extracted at room temperature (25 ° C.) for 15 hours. The obtained extract was filtered to give a pale yellow transparent extract solution (solid content: about 1.
2%) 500 ml were obtained.
【0029】 製造例5.シラン属植物抽出物溶液の調製(5) 製造例1に於いて、シラン属シランの球茎に代えてシラ
ン属フォルモサーナ(Bletilla formosana)の球茎を用
いるほかは製造例1と同様にして、淡黄色透明の抽出物
溶液(固形分含量:約3.0%)300mlを得た。Production Example 5 Preparation of silane plant extract solution (5) In the same manner as in Production Example 1, except that the corm of silane genus Bmosilla (Bletilla formosana) was used instead of the corm of silane of silane genus in Production Example 1, 300 ml of a clear extract solution (solid content: about 3.0%) were obtained.
【0030】 製造例6.シラン属植物抽出物粉末の調製 製造例1と同様にして得られた抽出物溶液を30mlに濃
縮した後凍結乾燥し、抽出物粉末9.9gを得た。Production Example 6 Preparation of Silane Plant Extract Powder The extract solution obtained in the same manner as in Production Example 1 was concentrated to 30 ml and freeze-dried to obtain 9.9 g of extract powder.
【0031】 製造例7.米糠抽出物加水分解物溶液の調製 米糠200gを、0.1規定水酸化ナトリウム水溶液800ml
に室温で24時間浸漬した。次に、不溶物をろ過で除き、
ろ液をアクチナーゼ、ペプシン及びトリプシンで順次処
理した。酵素処理は、酵素を各々10mg使用し、各酵素
の至適pHに於いて、それぞれ40℃に2時間保持するこ
とによって行った。ここに得られた酵素処理液をろ過し
て、黄色透明の米糠抽出物加水分解物溶液(固形分含
量:約1.0%)300mlを得た。Production Example 7 Preparation of rice bran extract hydrolyzate solution 200 g of rice bran, 800 ml of 0.1 N sodium hydroxide aqueous solution
For 24 hours at room temperature. Next, insoluble matter is removed by filtration,
The filtrate was sequentially treated with actinase, pepsin and trypsin. The enzyme treatment was carried out by using 10 mg of each enzyme and maintaining each at the optimum pH of each enzyme at 40 ° C. for 2 hours. The obtained enzyme-treated solution was filtered to obtain 300 ml of a yellow and transparent rice bran extract hydrolyzate solution (solid content: about 1.0%).
【0032】 実施例1.クリーム [A成分] 部 流動パラフィン 5.0 ヘキサラン (注) 4.0 パラフィン 5.0 グリセリルモノステアレート 2.0 ポリオキシエチレン(20)ソルビタンモノステアレート 6.0 ブチルパラベン 0.1 (注)株式会社テクノーブル製 トリオクタン酸グリセリル [B成分] 製造例1の抽出物溶液 5.0 コウジ酸 1.0 グリセリン 5.0 カルボキシメチルモノステアレート 0.1 メチルパラベン 0.1 モイストン・C (注) 1.0 精製水 全量が100部となる量 (注)株式会社テクノーブル製 NMF成分 [C成分] 香料 適量 上記のA成分とB成分を、それぞれ80℃以上に加熱した
後、攪拌混合した。これを50℃まで冷却した後、C成分
を加えてさらに攪拌混合してクリームを調製した。Embodiment 1 Cream [A component] part Liquid paraffin 5.0 hexalane (note) 4.0 paraffin 5.0 glyceryl monostearate 2.0 polyoxyethylene (20) sorbitan monostearate 6.0 butyl paraben 0.1 (note) Glyceryl trioctanoate manufactured by Technoble Co., Ltd. [Component B] Extract solution of Production Example 1 5.0 Kojic acid 1.0 Glycerin 5.0 Carboxymethyl monostearate 0.1 Methyl paraben 0.1 Moiston C (Note) 1 0.0 Purified water An amount that makes the total amount 100 parts. (Note) NMF component manufactured by Technoble Co., Ltd. [Component C] Fragrance Appropriate amount The above components A and B were each heated to 80 ° C. or higher, and then stirred and mixed. After cooling to 50 ° C., the C component was added and further stirred and mixed to prepare a cream.
【0033】 実施例2 乳液 [A成分] 部 流動パラフィン 6.0 ヘキサラン 4.0 ホホバ油 1.0 ポリオキシエチレン(20)ソルビタンモノステアレート 2.0 大豆レシチン 1.5 メチルパラベン 0.15 エチルパラベン 0.03 [B成分] 製造例2の抽出物溶液 5.0 L−アスコルビン酸−2−グルコシド 1.0 グリセリン 3.0 1、3−ブチレングリコール 2.0 カルボキシメチルセルロース 0.3 ヒアルロン酸ナトリウム 0.01 精製水 全量が100部となる量 [C成分] 香料 適量 上記のA成分とB成分をそれぞれ80℃以上に加熱した
後、攪拌混合した。これを50℃まで冷却した後、C成
分を加えてさらに攪拌混合して乳液を調製した。Example 2 Emulsion [Component A] Part Liquid paraffin 6.0 Hexaran 4.0 Jojoba oil 1.0 Polyoxyethylene (20) sorbitan monostearate 2.0 Soybean lecithin 1.5 Methylparaben 0.15 Ethylparaben 0.03 [Component B] Extract solution of Production Example 2 5.0 L-ascorbic acid-2-glucoside 1.0 glycerin 3.0 1,3-butylene glycol 2.0 carboxymethylcellulose 0.3 Sodium hyaluronate 0 .01 Amount of purified water to make the total amount 100 parts [Component C] Perfume Appropriate amount After heating each of the above components A and B to 80 ° C. or higher, they were mixed by stirring. After cooling to 50 ° C., the C component was added and further stirred and mixed to prepare an emulsion.
【0034】 実施例3 ローション [成分] 部 製造例1の抽出物溶液 5.0 アルブチン 1.0 エタノール 10.0 グリセリン 3.0 1、3−ブチレングリコール 2.0 メチルパラベン 0.2 クエン酸 0.1 クエン酸ナトリウム 0.3 カルボキシビニルポリマー 0.1 香料 適量 精製水 全量が100部となる量 上記の成分を混合してローションを調製した。Example 3 Lotion [Components] Part Extract Solution of Production Example 1 5.0 Arbutin 1.0 Ethanol 10.0 Glycerin 3.0 1, 3-butylene glycol 2.0 Methylparaben 0.2 Citric acid 1 Sodium citrate 0.3 Carboxyvinyl polymer 0.1 Perfume Appropriate amount Purified water Amount to make the total amount 100 parts The above components were mixed to prepare a lotion.
【0035】 実施例4 パック [成分] 部 ポリビニルアルコール 15.0 ヒドロキシメチルセルロース 5.0 プロピレングリコール 5.0 エタノール 10.0 メチルパラベン 0.2 製造例3の抽出物溶液 5.0 L−アスコルビン酸−2−リン酸エステルマグネシウム塩 1.0 香料 適量 精製水 全量が100部となる量 上記の成分を混合してパックを調製した。Example 4 Pack [Components] Part Polyvinyl alcohol 15.0 Hydroxymethylcellulose 5.0 Propylene glycol 5.0 Ethanol 10.0 Methylparaben 0.2 Extract solution of Production Example 3 5.0 L-ascorbic acid-2 -Magnesium phosphate ester 1.0 Appropriate amount of fragrance Purified water An amount that gives a total amount of 100 parts The above components were mixed to prepare a pack.
【0036】 実施例5 プレスパウダー [A成分] 部 ベンガラ 0.5 黄酸化鉄 1.5 黒酸化鉄 0.1 酸化チタン 10.0 ナイロンパウダー 4.0 セリサイト 全量が100部となる量 マイカ 23.0 タルク 25.0 製造例5の抽出物粉末 0.2 コウジ酸 1.0 [B成分] スクワラン 1.0 メチルポリシロキサン 4.0 プロピルパラベン 0.1 デヒドロ酢酸 0.1 流動パラフィン 2.0 香料 適量 上記のA成分とB成分をそれぞれ混合攪拌し混合した
後、200メッシュのタイラーメッシュの篩にかけ、得
られた混合粉末を金型に打型して均一なプレスパウダー
を調製した。Example 5 Press Powder [Component A] Part Bengala 0.5 Yellow Iron Oxide 1.5 Black Iron Oxide 0.1 Titanium Oxide 10.0 Nylon Powder 4.0 Sericite Amount of 100 parts of Mica 23 2.0 Talc 25.0 Extract powder of Production Example 5 0.2 Kojic acid 1.0 [Component B] squalane 1.0 Methylpolysiloxane 4.0 Propylparaben 0.1 Dehydroacetic acid 0.1 Liquid paraffin 2.0 Appropriate amount of fragrance The above components A and B were mixed and stirred, respectively, and then sieved with a 200-mesh Tyler mesh sieve. The obtained mixed powder was pressed into a mold to prepare a uniform press powder.
【0037】実施例6 クリーム 実施例1に於いて、コウジ酸1.0部の代わりにアルブ
チン1.0部を用いるほかは実施例1と同様にしてクリ
ームを調製した。Example 6 Cream A cream was prepared in the same manner as in Example 1 except that 1.0 part of kojic acid was used instead of 1.0 part of arbutin.
【0038】実施例7 クリーム 実施例1に於いて、コウジ酸1.0部の代わりにL−ア
スコルビン酸−2−リン酸エステルマグネシウム塩1.
0部を用いるほかは実施例1と同様にしてクリームを調
製した。Example 7 Cream In Example 1, the magnesium salt of L-ascorbic acid-2-phosphate was replaced with 1.0 part of kojic acid.
A cream was prepared in the same manner as in Example 1 except that 0 part was used.
【0039】実施例8 クリーム 実施例1に於いて、コウジ酸1.0部の代わりにL−ア
スコルビン酸−2−グルコシド1.0部を用いるほかは
実施例1と同様にしてクリームを調製した。Example 8 Cream A cream was prepared in the same manner as in Example 1 except that 1.0 part of L-ascorbic acid-2-glucoside was used instead of 1.0 part of kojic acid. .
【0040】実施例9 クリーム 実施例1に於いて、コウジ酸1.0部の代わりに4−n
−ブチルレゾルシノール1.0部を用いるほかは実施例
1と同様にしてクリームを調製した。Example 9 Cream In Example 1, 4-n was used in place of 1.0 part of kojic acid.
A cream was prepared in the same manner as in Example 1 except that 1.0 part of -butylresorcinol was used.
【0041】実施例10 クリーム 実施例1に於いて、コウジ酸1.0部の代わりにエラグ
酸1.0部を用いるほかは実施例1と同様にしてクリー
ムを調製した。Example 10 Cream A cream was prepared in the same manner as in Example 1 except that 1.0 part of ellagic acid was used instead of 1.0 part of kojic acid.
【0042】実施例11 クリーム 実施例1に於いて、コウジ酸1.0部の代わりに製造例
7の米糠抽出物加水分解物溶液2.0部を用いるほかは
実施例1と同様にしてクリームを調製した。Example 11 Cream A cream was prepared in the same manner as in Example 1 except that 2.0 parts of the rice bran extract hydrolyzate solution of Preparation Example 7 was used instead of 1.0 part of kojic acid. Was prepared.
【0043】実施例12 クリーム 実施例1に於いて、製造例1の抽出物溶液5.0部の代
わりに製造例5の抽出物溶液5.0部を用いるほかは実
施例1と同様にしてクリームを調製した。Example 12 Cream The procedure of Example 1 was repeated, except that 5.0 parts of the extract solution of Preparation Example 1 was replaced with 5.0 parts of the extract solution of Preparation Example 5. A cream was prepared.
【0044】比較例1 クリーム 実施例1に於いて、製造例1の抽出物溶液5.0部とコ
ウジ酸1.0部に代えて、コウジ酸1.0部を用いるほ
かは実施例1と同様にしてクリームを調製した。Comparative Example 1 Cream The procedure of Example 1 was repeated except that 5.0 parts of the extract solution of Production Example 1 and 1.0 part of kojic acid were used instead of 1.0 part of kojic acid. A cream was prepared in the same manner.
【0045】比較例2 クリーム 実施例6に於いて、製造例1の抽出物溶液5.0部とア
ルブチン1.0部に代えて、アルブチン1.0部を用い
るほかは実施例6と同様にしてクリームを調製した。Comparative Example 2 Cream The procedure of Example 6 was repeated, except that 1.0 part of arbutin was used instead of 5.0 parts of the extract solution of Preparation Example 1 and 1.0 part of arbutin. To prepare a cream.
【0046】比較例3 クリーム 実施例7に於いて、製造例1の抽出物溶液5.0部とL
−アスコルビン酸−2−リン酸エステルマグネシウム塩
1.0部に代えて、L−アスコルビン酸−2−リン酸エ
ステルマグネシウム塩1.0部を用いるほかは実施例1
と同様にしてクリームを調製した。Comparative Example 3 Cream In Example 7, 5.0 parts of the extract solution of Production Example 1 and L
Example 1 except that 1.0 part of L-ascorbic acid-2-phosphate magnesium salt was used instead of 1.0 part of ascorbic acid-2-phosphate magnesium salt
A cream was prepared in the same manner as described above.
【0047】比較例4 クリーム 実施例8に於いて、製造例1の抽出物溶液5.0部とL
−アスコルビン酸−2−グルコシド1.0部に代えて、
L−アスコルビン酸−2−グルコシド1.0部を用いる
ほかは実施例1と同様にしてクリームを調製した。Comparative Example 4 Cream In Example 8, 5.0 parts of the extract solution of Production Example 1 and L
-In place of 1.0 part of ascorbic acid-2-glucoside,
A cream was prepared in the same manner as in Example 1 except that 1.0 part of L-ascorbic acid-2-glucoside was used.
【0048】比較例5 クリーム 実施例9に於いて、製造例1の抽出物溶液5.0部と4
−n−ブチルレゾルシノール1.0部に代えて、4−n
−ブチルレゾルシノール1.0部を用いるほかは実施例
9と同様にしてクリームを調製した。Comparative Example 5 Cream In Example 9, 5.0 parts of the extract solution of Production Example 1 and 4
4-n-butyl resorcinol instead of 1.0 part
A cream was prepared in the same manner as in Example 9 except that 1.0 part of -butylresorcinol was used.
【0049】比較例6 クリーム 実施例10に於いて、製造例1の抽出物溶液5.0部と
エラグ酸1.0部に代えて、エラグ酸1.0部を用いる
ほかは実施例1と同様にしてクリームを調製した。Comparative Example 6 Cream The procedure of Example 10 was repeated except that 5.0 parts of the extract solution of Preparation Example 1 and 1.0 part of ellagic acid were used instead of 1.0 part of ellagic acid. A cream was prepared in the same manner.
【0050】比較例7 クリーム 実施例11に於いて、製造例1の抽出物溶液5.0部と
製造例7の米糠抽出物加水分解物溶液2.0部に代え
て、製造例7の米糠抽出物加水分解物溶液2.0部を用
いるほかは実施例1と同様にしてクリームを調製した。Comparative Example 7 Cream In Example 11, the rice bran of Production Example 7 was replaced with 5.0 parts of the extract solution of Production Example 1 and 2.0 parts of the rice bran extract hydrolyzate solution of Production Example 7. A cream was prepared in the same manner as in Example 1 except that 2.0 parts of the extract hydrolyzate solution was used.
【0051】試験例1 色素沈着抑制試験 ラン科シラン属植物抽出物と種々の美白剤とを組み合わ
せ用いたときの相乗効果を、有色モルモットを用いた色
素沈着抑制試験により調べた。Test Example 1 Pigmentation Inhibition Test The synergistic effect of a combination of a plant extract of the genus Orchidaceae with a whitening agent was examined by a pigmentation inhibition test using a colored guinea pig.
【0052】[試料]各成分を表1に示す固形分含量
(%)で含む水溶液を試料として用いた。[Sample] An aqueous solution containing each component at the solid content (%) shown in Table 1 was used as a sample.
【表1】 [Table 1]
【0053】表1に於いて、BS、KA、AL、AP
M、AG、EA、BR及びRHとは、それぞれ次のもの
を意味する。 BS:製造例1のシラン抽出物、KA:コウジ酸、A
L:アルブチン、APM:L−アスコルビン酸−2−リ
ン酸エステルマグネシウム塩、AG:L−アスコルビン
酸−2−グルコシド、EA:エラグ酸、BR:4−n−
ブチルレゾルシノール、RH:米糠抽出物加水分解物In Table 1, BS, KA, AL, AP
M, AG, EA, BR and RH mean the following, respectively. BS: silane extract of Production Example 1, KA: kojic acid, A
L: arbutin, APM: L-ascorbic acid-2-phosphate magnesium salt, AG: L-ascorbic acid-2-glucoside, EA: ellagic acid, BR: 4-n-
Butyl resorcinol, RH: hydrolyzate of rice bran extract
【0054】[試験方法]有色モルモット(雄、8週
齢)の背部中央部のタテ60mm×ヨコ30mmの体毛
を剃毛し、該部分を前後・左右四つに区画した。この区
画の一つに本発明試料を、残りの三つの区画に比較試料
A、BとC〜Fのいずれかを、それぞれ朝、夕各1回5
mlずつ6日間塗布すると共に、該塗布部位に毎日1回
朝の塗布直前に500mJ/cm2のUV−Bを照射
し、6日目の夕方に照射部位の色素沈着の状態を目視に
より観察し、以下の基準により評価した。[Test Method] The hair of a colored guinea pig (male, 8 weeks old) of 60 mm length × 30 mm width at the center of the back was shaved, and this part was divided into four parts: front, rear, left and right. The sample of the present invention was placed in one of the sections, and any of Comparative Samples A, B, and C to F was placed in the remaining three sections, once each in the morning and evening.
In addition to the application, the applied site was irradiated with UV-B of 500 mJ / cm 2 once daily immediately before application in the morning, and the state of pigmentation at the irradiated site was visually observed on the evening of the sixth day. Was evaluated according to the following criteria.
【0055】[色素沈着の評価基準] − : 色素沈着を認めない ± : 軽微な色素沈着を認める + : 軽度な色素沈着を認める 2+ : 中程度の色素沈着を認める 3+ : 重度な色素沈着を認める[Evaluation Criteria for Pigmentation]-: No pigmentation observed ±: Minor pigmentation observed +: Mild pigmentation observed 2+: Moderate pigmentation observed 3+: Severe pigmentation observed
【0056】[結果]結果を表2に示す。[Results] The results are shown in Table 2.
【表2】 [Table 2]
【0057】表2の結果から、本発明のラン科シラン属
植物抽出物と既存の美白剤を併用した場合、それら成分
を各々単独で使用した場合に比べて色素沈着の抑止効果
が著しく向上し、上記の併用によって美白効果が相乗的
に強められることが判る。。From the results shown in Table 2, it can be seen that the combined use of the orchidaceae silane plant extract of the present invention and an existing whitening agent significantly improves the effect of inhibiting pigmentation as compared with the case where each of these components is used alone. It can be seen that the whitening effect is synergistically enhanced by the above combination. .
【0058】試験例2 モニターテスト 実施例1、6〜11及び比較例1〜7の各クリームにつ
いて、モニターテストにより紫外線照射時の紅斑の発生
と色素沈着に対する抑制効果を調べた。Test Example 2 Monitor Test For each of the creams of Examples 1, 6 to 11 and Comparative Examples 1 to 7, the effect of suppressing erythema and pigmentation upon irradiation with ultraviolet rays was examined by a monitor test.
【0059】[試験方法]無作為に抽出した年齢18〜
55歳の女性70名を被験者とし、各被験者の左右の前
腕内側部に1cm×1cmの紫外線照射部をそれぞれ2カ所
設定した。UV−Bランプ(株式会社東芝製、FL20
−SE)を用い、予め測定しておいた各被験者の最小紅
斑量(MED)に相当する量の紫外線を1日1回
(朝)、3日間連続して照射した。紫外線照射開始日か
ら1カ月間連続して、紫外線照射期間内(最初の3日
間)は紫外線照射直後及び夕刻の1日2回、紫外線照射
期間経過後(4日目以降)は朝及び夕刻の1日2回、紫
外線照射部にクリームを塗布した。被験者70名を七つ
のグループに分け、各グループ10名に対し、実施例
1、6〜11及び比較例1〜7のクリームを塗布した。
各グループに対する塗布クリームの種類を表3に示す。[Test Method] Age 18-
Seventy-five 55-year-old women were set as subjects, and two 1 cm × 1 cm ultraviolet irradiation parts were set on the left and right inner forearms of each subject. UV-B lamp (FL20, manufactured by Toshiba Corporation)
-SE), the subject was irradiated with ultraviolet rays in an amount corresponding to the minimum erythema dose (MED) of each subject once measured once a day (morning) for three consecutive days. Consecutively for one month from the UV irradiation start date, during the UV irradiation period (first three days), immediately after UV irradiation and twice a day in the evening, and after the UV irradiation period (after the fourth day), in the morning and evening. The cream was applied to the ultraviolet irradiation part twice a day. Seventy subjects were divided into seven groups, and the creams of Examples 1, 6 to 11 and Comparative Examples 1 to 7 were applied to 10 groups.
Table 3 shows the types of applied creams for each group.
【0060】[0060]
【表3】 [Table 3]
【0061】1カ月間塗布した後、各被験者の紫外線照
射部の紅斑の発生状況及び色素沈着状態を目視で観察
し、以下の評価基準に基づいて評価した。After application for one month, the occurrence of erythema and the state of pigmentation in the ultraviolet-irradiated part of each subject were visually observed, and evaluated based on the following evaluation criteria.
【0062】[評価基準] A : 紅斑の発生及び色素沈着がなかった B : 紅斑の発生及び色素沈着が明らかに少なくなった C : 紅斑の発生及び色素沈着が少なくなった D : 紅斑の発生及び色素沈着の状態がクリーム使用前
と殆ど変わらなかった E : 紅斑の発生及び色素沈着がクリーム使用前よりか
えって多くなった[Evaluation Criteria] A: No erythema and no pigmentation B: Erythema and pigmentation clearly reduced C: Erythema and pigmentation decreased D: Erythema generation and The state of pigmentation was almost the same as before the use of the cream E: The occurrence of erythema and pigmentation increased rather than before the use of the cream
【0063】[結果]結果を表4に示す。[Results] The results are shown in Table 4.
【0064】[0064]
【表4】 [Table 4]
【0065】表4に示す通り、ラン科シラン属植物抽出
物と既存の美白剤とを併用した場合、美白剤単独に比べ
て、紫外線照射による紅斑の発生と色素沈着に対する抑
止効果が著しく増強される。As shown in Table 4, when the orchid silane plant extract and the existing whitening agent were used in combination, the effect of inhibiting erythema and pigmentation due to ultraviolet irradiation was significantly enhanced as compared with the whitening agent alone. You.
【0066】[0066]
【発明の効果】既存の美白剤にラン科シラン属植物抽出
物を組み合わせ配合してなる本発明の皮膚外用剤によれ
ば、それら配合成分の相乗効果により、美白作用が著し
く増強され、美白剤単独配合に比して皮膚の紅斑発生と
色素沈着がより顕著に抑制され、シミ、ソバカスの予防
・症状改善にすぐれた効果が発揮される。また、美白作
用が増強されることにより、所望の効果を得るに必要な
美白剤の配合量を低減させることができ、美白剤の高配
合時にしばしばみられる皮膚刺激等の副作用のない安全
性の高い皮膚外用剤の提供が可能となる。According to the external preparation for skin of the present invention obtained by combining an existing whitening agent with an extract of a plant belonging to the genus Orchidaceae, the whitening effect is remarkably enhanced by the synergistic effect of the components. Erythema development and pigmentation of the skin are more remarkably suppressed as compared with a single combination, and an excellent effect for preventing spots and freckles and improving symptoms is exhibited. In addition, by enhancing the whitening effect, the amount of the whitening agent required to obtain the desired effect can be reduced, and the safety without side effects such as skin irritation often observed when the whitening agent is highly incorporated. It is possible to provide a high skin external preparation.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 小椋貴子 大阪市西区北堀江1丁目6番8号共栄化学 工業株式会社内 Fターム(参考) 4C083 AA071 AA072 AA111 AA112 AA122 AB232 AB242 AB432 AB442 AC012 AC022 AC102 AC122 AC302 AC422 AC442 AC471 AC472 AC482 AC841 AC842 AD072 AD092 AD112 AD152 AD272 AD332 AD391 AD392 AD572 AD641 AD642 CC02 CC04 CC05 CC07 DD17 DD23 DD31 EE10 EE16 ────────────────────────────────────────────────── ─── Continuing from the front page (72) Inventor Takako Ogura 1-6-8 Kitahorie, Nishi-ku, Osaka Kyoei Chemical Industry Co., Ltd. F-term (reference) 4C083 AA071 AA072 AA111 AA112 AA122 AB232 AB242 AB432 AB442 AC012 AC022 AC102 AC122 AC302 AC422 AC442 AC471 AC472 AC482 AC841 AC842 AD072 AD092 AD112 AD152 AD272 AD332 AD391 AD392 AD572 AD641 AD642 CC02 CC04 CC05 CC07 DD17 DD23 DD31 EE10 EE16
Claims (2)
と、コウジ酸及びその誘導体、アルブチン、アスコルビ
ン酸及びその誘導体、エラグ酸、レゾルシノール誘導
体、胎盤抽出物、ソウハクヒ抽出液及び米糠抽出物加水
分解物から選ばれた美白剤の1種又は2種以上とを配合し
てなる皮膚外用剤。1. An extract of a plant belonging to the genus Silane of the family Orchidaceae, and hydrolysis of kojic acid and its derivatives, arbutin, ascorbic acid and its derivatives, ellagic acid, resorcinol derivatives, placenta extract, soybean sap extract and rice bran extract An external preparation for skin comprising one or more whitening agents selected from products.
アスコルビン酸−2−リン酸エステルマグネシウム塩、
L−アスコルビン酸−2−グルコシド、エラグ酸、4−
n−ブチルレゾルシノール、ソウハクヒ抽出液及び米糠
抽出物加水分解物から選ばれたものである請求項1に記
載の皮膚外用剤。2. A whitening agent comprising kojic acid, arbutin, L-
Magnesium ascorbic acid-2-phosphate ester,
L-ascorbic acid-2-glucoside, ellagic acid, 4-
The external preparation for skin according to claim 1, wherein the external preparation is selected from n-butyl resorcinol, a soybean extract, and a rice bran extract hydrolyzate.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000327317A JP5177827B2 (en) | 2000-10-26 | 2000-10-26 | Topical skin preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000327317A JP5177827B2 (en) | 2000-10-26 | 2000-10-26 | Topical skin preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002128654A true JP2002128654A (en) | 2002-05-09 |
| JP5177827B2 JP5177827B2 (en) | 2013-04-10 |
Family
ID=18804355
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000327317A Expired - Lifetime JP5177827B2 (en) | 2000-10-26 | 2000-10-26 | Topical skin preparation |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5177827B2 (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004107233A (en) * | 2002-09-17 | 2004-04-08 | Kuraray Co Ltd | External preparation for skin |
| KR100490172B1 (en) * | 2002-05-28 | 2005-05-17 | 주식회사 바이오랜드 | Cosmtic composition containing polysaccharides extracted from Bletilla striata Reichb. fil. |
| JP2005179217A (en) * | 2003-12-17 | 2005-07-07 | Nomura:Kk | Whitening agent |
| JP2006143632A (en) * | 2004-11-18 | 2006-06-08 | Kyoei Kagaku Kogyo Kk | Gel or cream external composition |
| FR2931358A1 (en) * | 2008-05-20 | 2009-11-27 | Oreal | Combination, useful e.g. in cosmetic composition to stimulate production of elastin, comprises hydrolyzate of rice protein and at least one monosaccharide derivative of ascorbic acid and a metal salt of phosphorylated ascorbic acid |
| CN105708731A (en) * | 2016-02-15 | 2016-06-29 | 珀莱雅化妆品股份有限公司 | Biological microcapsule having skin whitening efficacy and preparation method thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0616532A (en) * | 1992-03-17 | 1994-01-25 | Eisai Co Ltd | Whitening and beautifying agent |
| JPH0672845A (en) * | 1992-08-31 | 1994-03-15 | Eisai Co Ltd | Skin color-lightening agent |
| JPH07252128A (en) * | 1994-03-14 | 1995-10-03 | Mandamu:Kk | Skin external preparation |
| JP2000044460A (en) * | 1998-07-29 | 2000-02-15 | Tekunooburu:Kk | External preparation for skin |
-
2000
- 2000-10-26 JP JP2000327317A patent/JP5177827B2/en not_active Expired - Lifetime
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0616532A (en) * | 1992-03-17 | 1994-01-25 | Eisai Co Ltd | Whitening and beautifying agent |
| JPH0672845A (en) * | 1992-08-31 | 1994-03-15 | Eisai Co Ltd | Skin color-lightening agent |
| JPH07252128A (en) * | 1994-03-14 | 1995-10-03 | Mandamu:Kk | Skin external preparation |
| JP2000044460A (en) * | 1998-07-29 | 2000-02-15 | Tekunooburu:Kk | External preparation for skin |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100490172B1 (en) * | 2002-05-28 | 2005-05-17 | 주식회사 바이오랜드 | Cosmtic composition containing polysaccharides extracted from Bletilla striata Reichb. fil. |
| JP2004107233A (en) * | 2002-09-17 | 2004-04-08 | Kuraray Co Ltd | External preparation for skin |
| JP2005179217A (en) * | 2003-12-17 | 2005-07-07 | Nomura:Kk | Whitening agent |
| JP2006143632A (en) * | 2004-11-18 | 2006-06-08 | Kyoei Kagaku Kogyo Kk | Gel or cream external composition |
| FR2931358A1 (en) * | 2008-05-20 | 2009-11-27 | Oreal | Combination, useful e.g. in cosmetic composition to stimulate production of elastin, comprises hydrolyzate of rice protein and at least one monosaccharide derivative of ascorbic acid and a metal salt of phosphorylated ascorbic acid |
| CN105708731A (en) * | 2016-02-15 | 2016-06-29 | 珀莱雅化妆品股份有限公司 | Biological microcapsule having skin whitening efficacy and preparation method thereof |
| CN105708731B (en) * | 2016-02-15 | 2021-07-20 | 珀莱雅化妆品股份有限公司 | A kind of biological microcapsule with whitening effect and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| JP5177827B2 (en) | 2013-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2002060395A1 (en) | Cosmetics | |
| JP4495925B2 (en) | Collagen and elastin production promoter and anti-aging cosmetic containing the same | |
| JPH06199646A (en) | Skin beautifying cosmetic | |
| JPH08325130A (en) | Cosmetic | |
| JP2003034631A (en) | Fibroblast proliferation promoter and anti-aging cosmetic | |
| JP5177827B2 (en) | Topical skin preparation | |
| JP4592911B2 (en) | Cosmetics | |
| JP2006143670A (en) | Skin lotion | |
| JP4424561B2 (en) | Whitening cosmetics | |
| JP4828077B2 (en) | Topical skin preparation | |
| JP2005145878A (en) | Cosmetic and cosmetic compounding agent | |
| JP2014221754A (en) | Cosmetic | |
| JP4445658B2 (en) | Cosmetics | |
| JP2002128632A (en) | Cosmetic | |
| JP3987733B2 (en) | Fibroblast activator and skin external preparation containing the same | |
| JP2005145938A (en) | Active oxygen scavenger and cosmetic | |
| JP5057638B2 (en) | Topical skin preparation | |
| JP4500906B2 (en) | Cosmetic compounding agent and cosmetics containing the same | |
| JP2000044459A (en) | Skin preparation for external use | |
| JP4621958B2 (en) | Cosmetic compounding agent and cosmetics containing the same | |
| JP2005126394A (en) | Superoxide dismutase activity enhancer and cosmetic containing the same | |
| JP4843158B2 (en) | Cosmetics | |
| JP3818998B2 (en) | Whitening cosmetics | |
| JP2002003362A (en) | Skin care preparation | |
| JP5175411B2 (en) | Cosmetics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20071019 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20091015 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20091208 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100203 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20100720 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130107 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5177827 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |